Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ReposiTrak Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ReposiTrak Inc. November 20, 202483.6%
-
ReposiTrak Inc. November 20, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | ReposiTrak Inc. | Open-market sale | −18,906 | $13.16 | $248,803 |
| Dec 22, 2025 | ReposiTrak Inc. | Open-market sale | −1,641 | $13.20 | $21,661 |
| Nov 5, 2025 | ReposiTrak Inc. | Grant or award | +1,265 | — | — |
| Jul 2, 2025 | ReposiTrak Inc. | Grant or award | +925 | — | — |
| Jul 2, 2025 | ReposiTrak Inc. | Grant or award | +954 | — | — |
| Jan 20, 2025 | ReposiTrak Inc. | Grant or award | +847 | — | — |
| Nov 16, 2024 | ReposiTrak Inc. | Grant or award | +1,015 | — | — |
| Oct 22, 2024 | ReposiTrak Inc. | Option exercise | +7,912 | $10.00 | $79,120 |
| Jul 16, 2024 | ReposiTrak Inc. | Grant or award | +1,226 | — | — |
| Apr 15, 2024 | ReposiTrak Inc. | Grant or award | +1,183 | — | — |
| Jan 4, 2024 | ReposiTrak Inc. | Grant or award | +1,873 | — | — |
| Oct 19, 2023 | ReposiTrak Inc. | Grant or award | +2,100 | — | — |
| Jun 18, 2023 | ReposiTrak Inc. | Grant or award | +1,858 | — | — |
| Apr 10, 2023 | ReposiTrak Inc. | Grant or award | +2,986 | — | — |
| Jan 25, 2023 | ReposiTrak Inc. | Grant or award | +3,788 | — | — |
Questions about Ronald C. Hodge
What boards is Ronald C. Hodge on?
Ronald C. Hodge sits on the board of ReposiTrak Inc.
How long has Ronald C. Hodge served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.